If a Bear Market Is Coming, History Says These Are the Only ETFs You Need
Source: The Motley Fool
The article argues investors should prepare for an eventual bear market after the S&P 500 doubled from the start of 2023, while emphasizing the index's 515% gain since 2006, equivalent to 9.2% average annual returns. It favors Vanguard S&P 500 ETF (VOO) for broad-market exposure despite its 34.7% concentration in eight large technology holdings, and Schwab U.S. Dividend Equity ETF (SCHD) for a roughly 3% dividend yield and defensive sector exposure. SCHD has generated 13.6% average annual total returns since its October 2011 launch, though the article provides no near-term market forecast or company-specific catalyst.
Analysis
This is not a standalone risk-off signal; it is retail-facing allocation content arriving after a concentrated equity advance. The relevant mechanism is that VOO’s effective factor exposure is increasingly long mega-cap AI capex, long duration, and short dispersion—not broad, equal-weight U.S. growth. A modest index decline would therefore not validate a defensive-dividend rotation unless earnings revisions for NVDA, MSFT, AMZN, AVGO, and hyperscaler capex budgets deteriorate simultaneously.
SCHD should not be treated as a bond substitute: its payout is neither guaranteed nor insulated from cyclical earnings pressure, and its energy/financial/value exposure can lag sharply if the growth scare becomes a recession scare. Its relative performance is more likely to improve in a "rates down, growth slows but remains positive" regime than in a credit-event drawdown, where quality balance sheets and Treasury duration typically matter more. The immediate flow impact is likely negligible, but sustained retail rotation into dividend ETFs could modestly support large-cap value multiples over the next 1-3 months.
The contrarian point is that an index hedge alone may be poorly targeted. If concentration is the concern, a broad SPX selloff can be cushioned by lower rates and defensive sectors while the economically meaningful drawdown remains concentrated in expensive AI beneficiaries; equal-weight relative performance and semiconductor software/hardware dispersion are better indicators. Over 6-18 months, the key question is whether AI-related revenue converts into free cash flow fast enough to justify elevated capital intensity, not whether the S&P 500 has crossed an arbitrary bear-market threshold.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
Key Decisions for Investors
- No new directional trade from this article alone; treat it as a retail-flow/positioning watch item rather than an investable catalyst.
- For portfolios materially overweight NVDA, MSFT, AMZN, AVGO, and META, replace part of a blunt VOO hedge with a 1-3 month QQQ/SPY put-spread overlay only if Nasdaq breadth weakens and forward earnings revisions turn negative; this better targets concentration risk while limiting carry.
- Monitor SCHD/SPY relative strength and 10-year Treasury yields over the next 4-8 weeks. A sustained SCHD breakout alongside falling yields would support a tactical long SCHD versus short QQQ pair; invalidate if yields rise and cyclically sensitive dividend sectors lead.
- Use upcoming hyperscaler earnings to test the structural thesis: reduce AI-beta exposure if aggregate capex guidance rises while cloud/AI monetization guidance fails to accelerate, as that combination risks multiple compression before revenue estimates reset.
More News
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Apple says it will replace iPhone Duo units showing screen problems